Covering Wednesday, October 28, 2026. Regular-session closes and after-hours reactions are labeled separately; no Thursday price moves are included.
The market overview: modest index gains, stronger chips
The Associated Press closing summary put the Dow at 52,475.10, up 0.2%, and the Nasdaq at 26,549.85, up 0.3%. The S&P 500 gained approximately 0.3%, finishing near 7,744 [1]. Reuters reported a 1.8% advance in the Philadelphia Semiconductor Index [2]. This combination suggests that the headline market rise understated the strength in a particular technology segment.
Analysis: sector leadership matters because a broad index is not an evenly weighted vote by every listed company. Its performance can be driven by large constituents, while a smaller group of suppliers experiences much larger moves. Wednesday’s closes therefore describe the benchmark outcome, not a uniform improvement in business prospects. Investors assessing the session need both the index result and the company-specific reasons beneath it.
Microsoft: growth with a distinction between accounting measures
Microsoft’s release for the quarter ended September 30 showed revenue of $92.3 billion and operating income of $45.9 billion. Revenue grew 19% and operating income 21% from a year earlier. Azure revenue rose 48%. The company reported $4.92 in GAAP earnings per share and $4.89 on its adjusted measure, which excludes investment effects related to OpenAI [3]. Reuters observed a gain exceeding 4% in extended trading [2].
Analysis: the operating results and the accounting adjustments answer different questions. Revenue indicates the scale of business delivered during the period, operating income reflects a narrower profit measure, and investment gains or losses can affect the bottom line separately. Reading the reconciliation helps prevent a headline earnings-growth rate from being treated as a pure measure of recurring operating improvement. The after-hours move also remains distinct from the regular-session close.
Alphabet: revenue growth alongside negative free cash flow
Alphabet’s Wednesday release, reproduced by MarketScreener, reported about $127.6 billion of quarterly revenue. Its cash-flow reconciliation showed roughly $42.3 billion from operations and $51.4 billion of property-and-equipment purchases, leaving about $9.1 billion of negative free cash flow [4]. Reuters observed a decline exceeding 7% after hours [2]. These are reported earnings-period figures and a subsequent market reaction, not a forecast of Thursday’s closing price.
Analysis: negative free cash flow does not by itself mean a business is unprofitable or unable to meet its obligations. It means this cash-flow measure was below zero after the specified investment spending. The harder question is whether the spending produces worthwhile future returns and how it is financed in the meantime. That requires examining the balance sheet, investment timetable, and operating outlook together rather than treating one metric as a complete diagnosis.
Micron: a supplier’s report lifts the memory trade
Micron rose 5.9% in Wednesday’s regular session, according to Reuters, which connected the move to South Korean rival SK Hynix’s more-than-sevenfold quarterly profit increase [2]. The distinction matters: the catalyst was another company’s report, not a new Micron earnings release in this account. A peer’s results can change expectations for an industry without providing identical evidence for every business in it.
Analysis: investors often use a supplier or competitor as a clue about pricing, customer spending, or industry demand. But products, contracts, production costs, and customer concentration differ. A favorable read-through should therefore remain an inference to test against the company’s own disclosures. The stock-price reaction demonstrates that expectations changed; it does not establish that Micron will reproduce its rival’s growth rate or profitability.
Vertiv: infrastructure demand reaches the equipment providers
Vertiv gained 16.5% in the regular session [2]. Data Center Dynamics reported third-quarter sales of $4.31 billion, approximately 61% above a year earlier, and adjusted earnings of $2.21 per share. It also reported that the company lifted its full-year sales range to $14.45 billion–$14.85 billion [5]. The revenue outlook is management guidance, not completed full-year revenue.
Analysis: this business occupies a different position in the technology investment cycle from a cloud platform buying infrastructure. Equipment suppliers can benefit as customers build capacity, while those customers must eventually earn adequate returns from the completed facilities. Both outcomes can coexist for a time. Following the buyer and supplier separately helps explain why strong orders in one part of the chain do not automatically resolve valuation questions throughout it.
Boston Scientific: a reminder that the session was not all about AI
Boston Scientific fell 5.8% on Wednesday after reducing its annual profit outlook, Reuters reported [2]. Its decline provides an important counterpoint to the technology stories: market attention can be dominated by a few themes even while companies in unrelated industries face their own changes in expectations. A guidance revision concerns management’s view of the future, not just the latest quarter already reported.
Analysis: a company can be judged against expectations built into its share price as well as against its own history. Lower projected earnings can change that comparison even if many parts of the business remain intact. Readers should distinguish the fact of a forecast reduction from any unsupported explanation of its cause. The evidence cited here supports the guidance change and market reaction, not a broader claim about the entire medical-device industry.
How to read the five stories together
The common issue is the relationship between expectations, spending, and results. Microsoft and Alphabet brought attention to the buyers and operators of computing capacity; Micron and Vertiv highlighted parts of the supply chain; Boston Scientific showed the importance of guidance outside that theme. These are different business models with different risks, not interchangeable ways to describe a single market bet.
A useful follow-up is to ask what evidence would confirm or challenge each story. For a supplier, that could involve converting demand into delivered sales and cash; for an infrastructure buyer, it could involve earning returns on installed capacity. For any company, it includes comparing later results with the guidance actually issued. Wednesday’s moves identify where expectations shifted, but they are not personalized recommendations to buy or sell.